PS19 mice express human P301S tau, which causes FTD in humans1,50 and are widely used to model tauopathy relevant to AD51 due to robust tau accumulation from ~5–6 months across multiple brain regions49,52, including the MEC52, followed by spatial memory deficits at 6–8 months51–56. This evidence concerns the gene MAPT and tauopathy.